Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Julie Alipala, a longtime Zamboanga-based reporter for the Philippine Daily Inquirer who covered wars, conflicts, and peace ...

Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay ...

Endometrial cancer is one of the most common gynaecological cancers in high-income countries and, for many years, has been ...

Early signs of one of the most common reproductive cancers may now be spotted with near-perfect accuracy, thanks to a groundbreaking artificial intelligence model. For years, diagnosing endometrial ...

It has not become cancer yet and has not spread anywhere else. Doctors sometimes call this stage “carcinoma in situ” or Bowen disease. Stage 0 cancer may or may not be visible. If it is ...

Biliary Tract Cancer (BTC): KEYTRUDA may be combined with chemotherapy medicines to treat BTC, a cancer that affects the bile ducts or gallbladder. This treatment is for adults when the cancer has ...

A consultant gynaecologist who recommended Ann Summers products to an elderly patient with vaginal bleeding but who failed to carry out a thorough medical examination that might have detected cervical ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian, endometrial, and cervical cancers.

Sensitivity was 95% for type 2 endometrial cancers (serous carcinoma, clear cell carcinoma, and carcinosarcoma) but fell to 36% for atypical hyperplasia. Additional studies are underway to further ...